Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
Blombery P, Fox L, Ryland GL, Thompson ER, Lickiss J, McBean M, Yerneni S, Hughes D, Greenway A, Mechinaud F, Wood EM, Lieschke GJ, Szer J, Barbaro P, Roy J, Wight J, Lynch E, Martyn M, Gaff C, Ritchie D. Blombery P, et al. Haematologica. 2021 Jan 1;106(1):64-73. doi: 10.3324/haematol.2019.237693. Haematologica. 2021. PMID: 32054657 Free PMC article.
Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing.
Thompson ER, Nguyen T, Kankanige Y, Yeh P, Ingbritsen M, McBean M, Semple T, Mir Arnau G, Burbury K, Lee N, Khot A, Westerman D, Blombery P. Thompson ER, et al. Among authors: blombery p. Haematologica. 2021 Jan 1;106(1):313-315. doi: 10.3324/haematol.2020.260448. Haematologica. 2021. PMID: 32817290 Free PMC article. No abstract available.
CAR-T cell therapy: practical guide to routine laboratory monitoring.
Selim AG, Minson A, Blombery P, Dickinson M, Harrison SJ, Anderson MA. Selim AG, et al. Among authors: blombery p. Pathology. 2021 Apr;53(3):408-415. doi: 10.1016/j.pathol.2021.02.002. Epub 2021 Mar 5. Pathology. 2021. PMID: 33685719 Review.
Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.
Gould C, Lickiss J, Kankanige Y, Yerneni S, Lade S, Gandhi MK, Chin C, Yannakou CK, Villa D, Slack GW, Markham JF, Tam CS, Nelson N, Seymour JF, Dickinson M, Neeson PJ, Westerman D, Blombery P. Gould C, et al. Among authors: blombery p. Br J Haematol. 2021 Oct;195(1):113-118. doi: 10.1111/bjh.17789. Epub 2021 Aug 23. Br J Haematol. 2021. PMID: 34426978
Treatment approaches for patients with TP53-mutated mantle cell lymphoma.
Lew TE, Minson A, Dickinson M, Handunnetti SM, Blombery P, Khot A, Anderson MA, Ritchie D, Tam CS, Seymour JF. Lew TE, et al. Among authors: blombery p. Lancet Haematol. 2023 Feb;10(2):e142-e154. doi: 10.1016/S2352-3026(22)00355-6. Lancet Haematol. 2023. PMID: 36725119 Review.
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.
Manos K, Chong G, Keane C, Lee ST, Smith C, Churilov L, McKendrick J, Renwick W, Blombery P, Burgess M, Nelson NE, Fancourt T, Hawking J, Lin W, Scott AM, Barraclough A, Wight J, Grigg A, Fong CY, Hawkes EA. Manos K, et al. Among authors: blombery p. Leukemia. 2023 May;37(5):1092-1102. doi: 10.1038/s41375-023-01863-7. Epub 2023 Mar 11. Leukemia. 2023. PMID: 36906715 Clinical Trial.
200 results